Cargando…
The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and Aging
The concept of chelation therapy as a valuable therapeutic approach in neurological disorders led us to develop multi-target, non-toxic, lipophilic, brain-permeable compounds with iron chelation and anti-apoptotic properties for neurodegenerative diseases, such as Parkinson’s disease (PD), Alzheimer...
Autores principales: | Kupershmidt, Lana, Youdim, Moussa B. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001413/ https://www.ncbi.nlm.nih.gov/pubmed/36899898 http://dx.doi.org/10.3390/cells12050763 |
Ejemplares similares
-
Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical application
por: Benkler, Chen, et al.
Publicado: (2010) -
Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?
por: Moreau, Caroline, et al.
Publicado: (2018) -
Multi Target Neuroprotective and Neurorestorative Anti-Parkinson and Anti-Alzheimer Drugs Ladostigil and M30 Derived from Rasagiline
por: Youdim, Moussa B.H.
Publicado: (2013) -
Regional siderosis: a new challenge for iron chelation therapy
por: Cabantchik, Zvi Ioav, et al.
Publicado: (2013) -
Neuroprotection and Neuroregeneration in Alzheimer's Disease
por: Sugaya, Kiminobu, et al.
Publicado: (2012)